Vita Genomics Inc (賽亞基因科技), Taiwan’s largest genomics-based biotechnological and biopharmaceutical company, is in talks with potential buyers eyeing the company’s unique business model, a senior company executive said.
The development came after the New Taipei-based company announced plans to forge partnerships between testing facilities and hospitals aimed at growing mutual clientele and profits, Vita Genomics general manager Eddy Hsieh (謝春成) said.
Hsieh joined Vita Genomics in October 2013 when it was in the red and saw the company into profit last year.
Hsieh said he plans to build Vita Genomics into the healthcare industry’s “7-Eleven,” — the nation’s largest convenience store chain with more than 3,000 outlets.
“Some Taiwanese firms approached us with a view to acquiring Vita Genomics, attracted by its business potential,” Hsieh said.
He refused to name the interested parties for fear of sinking the deals prematurely except to say that they are in the technology sector.
Under Hsieh’s leadership, Vita Genomics is seeking the integration of the companies in its supply chain, including genomics testing facilities, pathology-testing laboratories and clinics.
There are more than 8,000 clinics in the nation and Vita Genomics aims to enter an alliance with at least 5,000 of them in the next three years, allowing them to overcome their inability to perform tests, Hsieh said.
That would give the company the top position in the industry with a 50 percent market share, he said, adding there are no competitors on the horizon.
However, integration is not an easy process, as many clinics prefer to maintain the “status quo,” Hsieh said, adding that like traditional grocery stores, they will be forced out of the market, if they reject strategic alliances.
The company would agree to acquisition bids that might help accelerate the integration, Hsieh said.
Vita Genomics has a market value of NT$3.2 billion (US$101.32 million) after the company booked NT$103 million in net income last year, or NT$2.37 per share, Hsieh said.
The company is in the process of increasing its capital by NT$800 million — from NT$460 million — and it is slated to list on the Emerging Stock Market in June and trade shares on the over-the-counter GRETAI Securities Market next year, Hsieh said.
“The capital increase is virtually completed as venture capital funds at home and overseas have lent their support,” Hsieh said.
China Development Financial Holding Corp (中華開發金控), Transglobe Life Insurance Co (全球人壽) and government-owned National Development Fund (國發基金) have contributed to the boost in capital, Hsieh said.
TAKING STOCK: A Taiwanese cookware firm in Vietnam urged customers to assess inventory or place orders early so shipments can reach the US while tariffs are paused Taiwanese businesses in Vietnam are exploring alternatives after the White House imposed a 46 percent import duty on Vietnamese goods, following US President Donald Trump’s announcement of “reciprocal” tariffs on the US’ trading partners. Lo Shih-liang (羅世良), chairman of Brico Industry Co (裕茂工業), a Taiwanese company that manufactures cast iron cookware and stove components in Vietnam, said that more than 40 percent of his business was tied to the US market, describing the constant US policy shifts as an emotional roller coaster. “I work during the day and stay up all night watching the news. I’ve been following US news until 3am
UNCERTAINTY: Innolux activated a stringent supply chain management mechanism, as it did during the COVID-19 pandemic, to ensure optimal inventory levels for customers Flat-panel display makers AUO Corp (友達) and Innolux Corp (群創) yesterday said that about 12 to 20 percent of their display business is at risk of potential US tariffs and that they would relocate production or shipment destinations to mitigate the levies’ effects. US tariffs would have a direct impact of US$200 million on AUO’s revenue, company chairman Paul Peng (彭雙浪) told reporters on the sidelines of the Touch Taiwan trade show in Taipei yesterday. That would make up about 12 percent of the company’s overall revenue. To cope with the tariff uncertainty, AUO plans to allocate its production to manufacturing facilities in
Six years ago, LVMH’s billionaire CEO Bernard Arnault and US President Donald Trump cut the blue ribbon on a factory in rural Texas that would make designer handbags for Louis Vuitton, one of the world’s best-known luxury brands. However, since the high-profile opening, the factory has faced a host of problems limiting production, 11 former Louis Vuitton employees said. The site has consistently ranked among the worst-performing for Louis Vuitton globally, “significantly” underperforming other facilities, said three former Louis Vuitton workers and a senior industry source, who cited internal rankings shared with staff. The plant’s problems — which have not
TARIFF CONCERNS: The chipmaker cited global uncertainty from US tariffs and a weakening economic outlook, but said its Singapore expansion remains on track Vanguard International Semiconductor Corp (世界先進), a foundry service provider specializing in producing power management and display driver chips, yesterday withdrew its full-year revenue projection of moderate growth for this year, as escalating US tariff tensions raised uncertainty and concern about a potential economic recession. The Hsinchu-based chipmaker in February said revenues this year would grow mildly from last year based on improving supply chain inventory levels and market demand. At the time, it also anticipated gradual quarter revenue growth. However, the US’ sweeping tariff policy has upended the industry’s supply chains and weakened economic prospects for the world economy, it said. “Now
RSS